Abstract
This commentary highlights the validation study by Lih et al that supports the use of precision medicine for improved clinical trials.
Published by Elsevier Inc.
MeSH terms
-
Clinical Trials as Topic
-
Genetic Association Studies
-
High-Throughput Nucleotide Sequencing / methods
-
High-Throughput Nucleotide Sequencing / standards
-
Humans
-
Laboratories / standards*
-
Molecular Diagnostic Techniques / methods
-
Molecular Diagnostic Techniques / standards
-
Molecular Targeted Therapy
-
Neoplasms / diagnosis
-
Neoplasms / genetics
-
Neoplasms / therapy
-
Precision Medicine* / methods
-
Precision Medicine* / standards
-
Reproducibility of Results